Pediatrix Medical Group Inc (MD) is expecting 99.61% growth in the next quarter: What can investors do to maximize their returns?

On Friday, Pediatrix Medical Group Inc (NYSE: MD) opened higher 23.46% from the last session, before settling in for the closing price of $12.32. Price fluctuations for MD have ranged from $6.62 to $13.02 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales drop of Healthcare Sector giant was -7.30%. Company’s average yearly earnings per share was noted 2.03% at the time writing. With a float of $84.54 million, this company’s outstanding shares have now reached $85.87 million.

Let’s determine the extent of company efficiency that accounts for 8070 employees. In terms of profitability, gross margin is 20.32%, operating margin of -0.23%, and the pretax margin is -13.63%.

Pediatrix Medical Group Inc (MD) Insider Activity

A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Pediatrix Medical Group Inc is 1.54%, while institutional ownership is 102.00%. The most recent insider transaction that took place on Aug 30 ’24, was worth 119,769. In this transaction Chief Executive Officer of this company sold 11,100 shares at a rate of $10.79, taking the stock ownership to the 170,001 shares. Before that another transaction happened on Aug 30 ’24, when Company’s Officer proposed sale 11,100 for $10.79, making the entire transaction worth $119,756.

Pediatrix Medical Group Inc (MD) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around 2.03% per share during the next fiscal year.

Pediatrix Medical Group Inc (NYSE: MD) Trading Performance Indicators

Check out the current performance indicators for Pediatrix Medical Group Inc (MD). In the past quarter, the stock posted a quick ratio of 1.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.80. Likewise, its price to free cash flow for the trailing twelve months is 16.06.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.06, a number that is poised to hit 0.36 in the next quarter and is forecasted to reach 1.46 in one year’s time.

Technical Analysis of Pediatrix Medical Group Inc (MD)

Looking closely at Pediatrix Medical Group Inc (NYSE: MD), its last 5-days average volume was 1.06 million, which is a jump from its year-to-date volume of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 47.89%. Additionally, its Average True Range was 0.58.

During the past 100 days, Pediatrix Medical Group Inc’s (MD) raw stochastic average was set at 97.61%, which indicates a significant increase from 93.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.37% in the past 14 days, which was higher than the 59.30% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $11.63, while its 200-day Moving Average is $9.38. However, in the short run, Pediatrix Medical Group Inc’s stock first resistance to watch stands at $16.10. Second resistance stands at $16.99. The third major resistance level sits at $18.56. If the price goes on to break the first support level at $13.64, it is likely to go to the next support level at $12.07. Should the price break the second support level, the third support level stands at $11.18.

Pediatrix Medical Group Inc (NYSE: MD) Key Stats

There are currently 85,866K shares outstanding in the company with a market cap of 1.61 billion. Presently, the company’s annual sales total 1,995 M according to its annual income of -60,410 K. Last quarter, the company’s sales amounted to 504,300 K and its income totaled -153,030 K.